Related Experiment Videos

Gremlin - a putative pathogenic player in progressive renal disease

Vincent Dolan1, Madeline Murphy, Pilar Alarcon

  • 1Centre for Integrative Biology, Conway Institute of Biomolecular and Biomedical Research, Department of Medicine and Therapeutics, University College Dublin, The Dulin Molecular Medicine Centre, Belfield, Ireland. vincent.dolan@ucd.ie

Insights

Progressive renal fibrosis leads to kidney failure, and current treatments are insufficient. Gremlin, a bone morphogenetic protein regulator, shows promise as a novel therapeutic target for halting kidney disease progression.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Developmental Biology

Background:

  • Progressive renal fibrosis is a major cause of end-stage renal disease.
  • Existing therapies for chronic renal failure only slow disease progression, failing to halt it.
  • Understanding the mechanisms of glomerulosclerosis and tubulointerstitial fibrosis is crucial for developing new treatments.

Purpose of the Study:

  • To investigate the role of gremlin in progressive renal diseases.
  • To explore gremlin as a potential therapeutic target for kidney fibrosis.

Main Methods:

  • The study implicates gremlin, a regulator of bone morphogenetic proteins (BMPs).
  • Gremlin's involvement in glomerulosclerosis, tubulointerstitial fibrosis, and cellular hypertrophy was examined.

Main Results:

  • Gremlin has been implicated in key fibrotic processes in the kidney.
  • The findings suggest gremlin's significant role in the pathogenesis of progressive renal diseases.

Conclusions:

  • Gremlin emerges as a potential novel therapeutic target for progressive renal diseases.
  • Targeting gremlin may offer a new strategy to halt or reverse kidney fibrosis and failure.

Related Concept Videos